Pharma Industry News

Study shows AZ’s COVID-19 jab did not increase the rate of rare blood clots after second dose

Rate of rare blood clots with low platelets after the second dose is comparable to background rates observed in unvaccinated populationsOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]